Ultragenyx Pharmaceutical (RARE)
Ultragenyx Pharmaceutical (RARE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- RARE last traded at $16.50 on 2026-11-20, -4.18% for the session.
- Ultragenyx Pharmaceutical: market cap $1.68B, revenue $730.28M over the last four quarters, next earnings 2027-02-11.
- Over the past year RARE returned -48.21%, with a year-to-date return of -28.26%.